Facilities White Papers & Case Studies

  1. Optimizing Upstream Process Development To Increase mAb Titers 3/28/2025

    Uncover how we were able to help a client develop an efficient upstream process for a novel monoclonal antibody (mAb), resulting in a more than 100% increase in titers.

  2. A Translational Mouse Model For Non-Genetic Heterotopic Ossification 3/28/2025

    Reproducing the thermal lesion/tenotomy-induced mouse model can help overcome the challenge of unpredictable heterotopic ossification localization and enable the development of targeted interventions.

  3. Scalable Production Of High-Purity Nanobodies Using Yeast Expression System 9/8/2025

    Leverage scalable K. pastoris expression systems to produce high-quality nanobodies for cutting-edge therapeutic, diagnostic, and research applications.

  4. Leveraging Surface Plasmon Resonance For Characterizing Ternary Complexes 6/13/2025

    Uncover how Surface Plasmon Resonance (SPR) can be used to gain real-time, label-free insights into PROTAC binding kinetics and ternary complex formation.

  5. Robust, Scalable Strategy For Monodisperse Nanosuspensions Of Poorly Soluble Drugs 5/16/2025

    By tailoring the formulation strategy, selecting the appropriate excipients, and fine-tuning process conditions, see how our team was able to improve bioavailability and in vivo exposure.

  6. Organizational Assessment For A Large MedTech Company 6/5/2025

    Explore an organizational assessment run for a medical technology company specializing in tissue repair and regeneration, and the actionable recommendations provided to facilitate future growth.

  7. Streamlined Facility Design: A Success Story 4/29/2024

    Examine how one medium-sized US company's need for a new aseptic compounding and fill-finish facility was addressed with a tailored solution within a challenging time-frame.

  8. Acoustic Inspection Helps Campbell River Optimize Inspection Program 9/6/2024

    In this case study, explore how incorporating the SL-RAT into their maintenance program has realized significant savings for the city of Campbell River.

  9. Use Of Epiontis ID In A Phase 2 Psoriasis Trial 9/25/2025

    Mirikizumab’s Phase 2 trial explores IL-23 inhibition in psoriasis, measuring immune cell changes to assess its potential for long-term disease control and flare-up prevention.

  10. How We Used Intelligent Automation to Transform Vendor Selection 7/2/2025

    Discover how your small biotech can achieve faster timelines, improved cost control, and more strategic, transparent choices with a platform leveraging intelligent automation.